NCT03573310 2025-12-18A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDSJanssen Research & Development, LLCPhase 1 Completed114 enrolled